Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?


YUCEL S., AKKAYA E., GUNTEKIN E., KUKUL E., DANISMAN A., Akman S., ...More

UROLOGY, vol.65, no.2, pp.369-373, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 65 Issue: 2
  • Publication Date: 2005
  • Doi Number: 10.1016/j.urology.2004.09.036
  • Journal Name: UROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.369-373
  • Akdeniz University Affiliated: Yes

Abstract

Objectives. To assess the clinical efficacy of tolterodine prescribed to children with non-neurogenic daytime urinary incontinence secondary to overactive bladder who had previously failed to improve with oral oxybutynin treatment and its relation to the side-effect profile and compliance status.